Published in Am J Psychiatry on December 01, 1999
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) (2005) 3.92
Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict (2005) 3.89
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov (2009) 3.26
Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology (2010) 2.74
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol (2004) 1.58
Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (2004) 1.54
ADHD and smoking: from genes to brain to behavior. Ann N Y Acad Sci (2008) 1.46
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol (2007) 1.46
Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology (Berl) (2007) 1.44
Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry (2004) 1.38
Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology (2010) 1.31
Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling. J Neurosci (2010) 1.20
An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother (2011) 1.15
Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology (Berl) (2006) 1.10
Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches. Behav Neurosci (2011) 1.08
Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial. Nicotine Tob Res (2011) 1.05
Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments. Neuropharmacology (2010) 0.97
Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology (2011) 0.97
Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav (2011) 0.97
Nicotinic α5 subunits drive developmental changes in the activation and morphology of prefrontal cortex layer VI neurons. Biol Psychiatry (2011) 0.94
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial. J Dual Diagn (2009) 0.92
Nicotinic receptors in neurodegeneration. Curr Neuropharmacol (2013) 0.91
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology (Berl) (2011) 0.91
Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors. Br J Pharmacol (2013) 0.91
Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology (Berl) (2011) 0.89
Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. J Am Acad Child Adolesc Psychiatry (2010) 0.89
Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity. Psychopharmacology (Berl) (2011) 0.88
Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder. Genes Brain Behav (2007) 0.88
Complex relationships of nicotinic receptor actions and cognitive functions. Biochem Pharmacol (2013) 0.88
Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit/hyperactivity disorder (ADHD). Hum Psychopharmacol (2009) 0.87
Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Psychopharmacology (Berl) (2004) 0.85
nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. Schizophr Res (2016) 0.84
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders. Biochem Pharmacol (2015) 0.84
A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (2013) 0.83
Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats. Psychopharmacology (Berl) (2012) 0.83
Potential therapeutic uses of mecamylamine and its stereoisomers. Pharmacol Biochem Behav (2013) 0.82
The enhancement of contextual fear conditioning by ABT-418. Behav Pharmacol (2010) 0.82
Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex. Cell Mol Life Sci (2014) 0.82
Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats. Psychopharmacology (Berl) (2012) 0.81
Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics. Biochem Pharmacol (2013) 0.80
Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia. Psychopharmacology (Berl) (2013) 0.80
H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization. Psychopharmacology (Berl) (2003) 0.80
Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish. Psychopharmacology (Berl) (2013) 0.77
Neurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career. Biochem Pharmacol (2011) 0.77
A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD. Behav Brain Funct (2008) 0.77
Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD. J Neurochem (2011) 0.77
Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder. Pharmgenomics Pers Med (2014) 0.76
Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats. Eur J Pharmacol (2014) 0.76
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis. Pediatrics (2014) 0.76
Cigarette smoking and ADHD: An examination of prognostically relevant smoking behaviors among adolescents and young adults. Psychol Addict Behav (2016) 0.75
Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation. Front Mol Neurosci (2015) 0.75
Nicotinic α4β2 cholinergic receptor influences on dorsolateral prefrontal cortical neuronal firing during a working memory task. J Neurosci (2017) 0.75
Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date. CNS Drugs (2014) 0.75
DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry (1994) 4.17
Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry (1995) 3.98
Inhibition of membrane-bound adenosine triphosphatase and of cation transport in Streptococcus faecalis by N,N'-dicyclohexylcarbodiimide. J Biol Chem (1969) 3.58
Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry (2001) 3.16
Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry (1996) 3.05
Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry (1999) 2.95
Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet (2000) 2.95
Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry (2000) 2.80
Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1997) 2.66
Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am J Hum Genet (2000) 2.59
Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry (1996) 2.54
Stable behavioral inhibition and its association with anxiety disorder. J Am Acad Child Adolesc Psychiatry (1992) 2.31
Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med (2000) 2.23
Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry (1995) 2.22
Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology (1997) 2.21
Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 2.21
Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA (1998) 2.20
Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype? J Am Acad Child Adolesc Psychiatry (1997) 2.15
ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry (1997) 2.09
Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry (1999) 2.07
The release of bound adenosine triphosphatase from isolated bacterial membranes and the properties of the solubilized enzyme. J Biol Chem (1965) 2.04
[In-hospital major complications associated with rotational atherectomy: experience with 800 patients at a single center]. Rev Esp Cardiol (2001) 2.00
Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (1995) 1.98
Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry (1997) 1.96
Biased maternal reporting of child psychopathology? J Am Acad Child Adolesc Psychiatry (1998) 1.89
Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry (1998) 1.82
Toward a new psychometric definition of social disability in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1996) 1.77
Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry (1997) 1.68
Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry (2000) 1.67
Diagnostic accuracy of the Child Behavior Checklist scales for attention-deficit hyperactivity disorder: a receiver-operating characteristic analysis. J Consult Clin Psychol (1994) 1.65
Comorbidity between ADDH and learning disability: a review and report in a clinically referred sample. J Am Acad Child Adolesc Psychiatry (1992) 1.61
Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry (1997) 1.59
A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1995) 1.59
Carbodiimide-resistant membrane adenosine triphosphatase in mutants of Streptococcus faecalis. I. Studies of the mechanism of resistance. J Biol Chem (1972) 1.58
Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis (1997) 1.56
A pilot study of neuropsychological function in girls with ADHD. J Am Acad Child Adolesc Psychiatry (1997) 1.56
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry (1996) 1.55
Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry (1998) 1.53
A genetic defect in retention of potassium by Streptococcus faecalis. Biochemistry (1967) 1.51
Patterns of alcohol and drug use in adolescents can be predicted by parental substance use disorders. Pediatrics (2000) 1.50
Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am (1999) 1.48
The stimulants revisited. Child Adolesc Psychiatr Clin N Am (2000) 1.48
Behavioral inhibition in childhood: a risk factor for anxiety disorders. Harv Rev Psychiatry (1997) 1.48
Psychiatric, neuropsychological, and psychosocial features of DSM-IV subtypes of attention-deficit/hyperactivity disorder: results from a clinically referred sample. J Am Acad Child Adolesc Psychiatry (1998) 1.45
Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry (1989) 1.45
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1994) 1.44
Growth deficits in children treated with desipramine: a controlled study. J Am Acad Child Adolesc Psychiatry (1992) 1.44
Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J Clin Child Psychol (1998) 1.42
Nortriptyline in the treatment of ADHD: a chart review of 58 cases. J Am Acad Child Adolesc Psychiatry (1993) 1.41
Fibrinolysis of loculated pleural effusion in malignant mesothelioma. Singapore Med J (2004) 1.40
A pharmacological approach to the quagmire of comorbidity in juvenile mania. J Am Acad Child Adolesc Psychiatry (1996) 1.39
Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict (1997) 1.37
DSM-IV field trials for the disruptive behavior disorders: symptom utility estimates. J Am Acad Child Adolesc Psychiatry (1994) 1.36
Methodological complexities in the diagnosis of major depression in youth: an analysis of mother and youth self-reports. J Child Adolesc Psychopharmacol (2001) 1.36
Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample. J Consult Clin Psychol (1997) 1.35
Do attention deficit hyperactivity disorder and major depression share familial risk factors? J Nerv Ment Dis (1997) 1.33
The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD. Arch Dis Child (2005) 1.32
Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study. Arch Gen Psychiatry (1988) 1.32
The stimulants. Psychiatr Clin North Am (1992) 1.29
Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol (1993) 1.28
A bacteriological survey of the domestic environment. J Appl Bacteriol (1978) 1.28
Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis (2001) 1.28
A controlled study of behavioral inhibition in children of parents with panic disorder and depression. Am J Psychiatry (2000) 1.28
The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med (2008) 1.26
Comorbidity of juvenile obsessive-compulsive disorder with disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry (1996) 1.25
Correspondence between DSM-III-R and DSM-IV attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1997) 1.25
Attention-deficit disorder and conduct disorder in girls: evidence for a familial subtype. Biol Psychiatry (2000) 1.24
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry (1996) 1.23
Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry (1998) 1.23
Are perinatal complications relevant to the manifestation of ADD? Issues of comorbidity and familiality. J Am Acad Child Adolesc Psychiatry (1993) 1.23
Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry (1998) 1.23
Anxiety disorders and tic severity in juveniles with Tourette's disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.22
How reliable are maternal reports of their children's psychopathology? One-year recall of psychiatric diagnoses of ADHD children. J Am Acad Child Adolesc Psychiatry (1995) 1.22
Attention deficit disorder and conduct disorder: longitudinal evidence for a familial subtype. Psychol Med (1997) 1.22
Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry (1998) 1.21
Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol (1995) 1.21
Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med (2008) 1.19
Simulation for assessing statistical methods of biologic terrorism surveillance. MMWR Morb Mortal Wkly Rep (2005) 1.19
Comparison of syndromic surveillance and a sentinel provider system in detecting an influenza outbreak--Denver, Colorado, 2003. MMWR Morb Mortal Wkly Rep (2005) 1.19
Membrane adenosine triphosphatase from Streptococcus faecalis. Molecular weight, subunit structure, and amino acid composition. J Biol Chem (1970) 1.19
Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry (1996) 1.19
Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry (1995) 1.18
A controlled family study of children with DSM-IV bipolar-I disorder and psychiatric co-morbidity. Psychol Med (2009) 1.18
Diagnostic continuity between child and adolescent ADHD: findings from a longitudinal clinical sample. J Am Acad Child Adolesc Psychiatry (1998) 1.18
Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol Dis (1998) 1.18
A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry (2001) 1.16
Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry (2000) 1.16
Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemiol (2000) 1.16